Gyermekkori daganatok: vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 158 Also abroad 2483

158 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.

1/2. fázisTaking people
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Where
London
Életkor
6 hónap to 17 év
People
370 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00
1/2. fázisTaking people
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Where
Glasgow, Liverpool, Sutton
Életkor
1 év to 17 év
People
70 worldwide
Run by
Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00
2. fázisTaking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Cambridge, Glasgow, London
Életkor
12 év and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
1. fázisTaking people
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Where
London, Manchester, Newcastle upon Tyne
Életkor
0 év to 18 év
People
30 worldwide
Run by
Autolus Limited
See details and how to joinNCT06173518 · EU 2023-506307-26-00
1/2. fázisTaking people
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Where
Bloomsbury, Manchester
Életkor
12 év and over
People
83 worldwide
Run by
AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00
No phaseTaking people
Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma
Where
London, Manchester
Életkor
17 év and over
People
30
Run by
The Christie NHS Foundation Trust
See details and how to joinNCT06434493
4. fázisTaking people
Asciminib Roll-over Study
Where
London, Oxford
Életkor
7 év to 100 év
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
2. fázisTaking people
177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
Where
Glasgow, London
Életkor
18 hónap to 64 év
People
24 worldwide
Run by
Jakob Stenman
See details and how to joinNCT04903899 · EU 2023-503684-42-00
No phaseTaking people
PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy
Where
Sutton
Életkor
3 év and over
People
173
Run by
Institute of Cancer Research, United Kingdom
See details and how to joinNCT02973828
1/2. fázisTaking people
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Where
Edinburgh, London, Manchester, Sutton
Életkor
12 év and over
People
840 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00
3. fázisTaking people
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Where
Leicester, Surrey
People
200 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00
1/2. fázisTaking people
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Where
Cardiff, Leeds, Liverpool, London, Manchester, Oxfordshire, Plymouth
Életkor
2 év and over
People
420 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00
2/3. fázisTaking people
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Where
Leeds, London, Manchester Withington, Shirley Southampton
People
1541 worldwide
Run by
Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00
1/2. fázisTaking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Birmingham, Cardiff, London, Newcastle upon Tyne, Sutton
Életkor
6 hónap to 25 év
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
No phaseTaking people
Met Non Small Cell Cancer Registry (MOMENT)
Where
Bedford, Birmingham, Bournemouth, Cardiff, Chelsea, Harrow, Huddersfield, Liverpool, London, Preston, Swindon, Torquay
People
700 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT05376891
1. fázisTaking people
Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
Where
London
Életkor
12 év and over
People
464 worldwide
Run by
Debiopharm International SA
See details and how to joinNCT04855656 · EU 2023-510063-35-00
1/2. fázisTaking people
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Where
Edinburgh, London, Manchester, Newcastle
Életkor
16 év and over
People
85 worldwide
Run by
AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00
3. fázisTaking people
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Where
Aberdeen, Derby, Leicester, Lincoln, London, Oxford, Southampton, Sutton
Életkor
12 év and over
People
468 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00
3. fázisTaking people
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Where
Birmingham, London
People
115 worldwide
Run by
Pierre Fabre Medicament
See details and how to joinNCT03394365 · EU 2024-516622-57-00
1/2. fázisTaking people
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Where
London, Manchester, Surrey
Életkor
12 év and over
People
255 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00
1/2. fázisTaking people
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Where
Manchester, Oxford
Életkor
12 év and over
People
161 worldwide
Run by
AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00
1. fázisTaking people
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Where
Manchester
Életkor
15 év and over
People
282 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06276491
No phaseTaking people
BEAT-Breast: Trial of DE-iPTV in Patients With Primary Breast Cancer With Brain Metastases Who Are Not Suitable for Stereotactic Radiotherapy.
Where
London, Oxford
Életkor
16 év to 100 év
People
42
Run by
Imperial College London
See details and how to joinNCT06611306
2/3. fázisTaking people
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Where
Belfast, London, Southampton
Életkor
18 év and over
People
740 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00
1/2. fázisTaking people
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Where
Birmingham, Cardiff, Newcastle upon Tyne, Sutton
Életkor
1 hónap to 17 év
People
50 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00